Bayer Launches Menopause Tablet Julina in Japan; First Market To Launch In World
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Bayer HealthCare of Osaka launched its menopause and postmenopausal treatment Julina (estradiol E2) in Japan Sept. 16, making Japan the first market to launch the drug in the world, the company announced
You may also be interested in...
Japan To List Nine Composites For National Health Insurance Coverage
TOKYO - At its Dec. 3 plenary meeting, Chuikyo (the Central Social Insurance and Medical Council), the government-private body that sets Japan's medical and pharmaceutical policies, approved the listing of nine composites for 13 pharmaceutical products, including the relisting of Fujimoto's Thaled (thalidomide) for multiple myeloma
Japan To List Nine Composites For National Health Insurance Coverage
TOKYO - At its Dec. 3 plenary meeting, Chuikyo (the Central Social Insurance and Medical Council), the government-private body that sets Japan's medical and pharmaceutical policies, approved the listing of nine composites for 13 pharmaceutical products, including the relisting of Fujimoto's Thaled (thalidomide) for multiple myeloma
Pfizer And Astellas Drugs Added To Japan MHLW's NHI Coverage List
TOKYO - Japan's Ministry of Health, Labor and Welfare released details of 11 new drugs approved at the Aug. 27 Central Social Insurance Medical Council (Chuikyo) general meeting for National Health Insurance coverage listing